Asensus Surgical, Inc.
ASXC · AMEX
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $8,577 | $7,087 | $8,232 | $3,175 |
| % Growth | 21% | -13.9% | 159.3% | – |
| Cost of Goods Sold | $13,155 | $10,872 | $11,096 | $5,166 |
| Gross Profit | -$4,578 | -$3,785 | -$2,864 | -$1,991 |
| % Margin | -53.4% | -53.4% | -34.8% | -62.7% |
| R&D Expenses | $37,023 | $28,942 | $19,348 | $16,621 |
| G&A Expenses | $19,155 | $20,172 | $19,323 | $14,137 |
| SG&A Expenses | $36,076 | $34,928 | $32,718 | $27,201 |
| Sales & Mktg Exp. | $16,921 | $14,756 | $13,395 | $13,064 |
| Other Operating Expenses | $453 | $7,708 | $11,254 | $10,801 |
| Operating Expenses | $73,099 | $71,578 | $63,320 | $54,623 |
| Operating Income | -$79,468 | -$75,679 | -$64,619 | -$60,389 |
| % Margin | -926.5% | -1,067.9% | -785% | -1,902% |
| Other Income/Exp. Net | $11 | $436 | $2,382 | -$439 |
| Pre-Tax Income | -$78,119 | -$75,243 | -$62,237 | -$60,828 |
| Tax Expense | $314 | $318 | $225 | -$1,516 |
| Net Income | -$78,433 | -$75,561 | -$62,462 | -$59,312 |
| % Margin | -914.5% | -1,066.2% | -758.8% | -1,868.1% |
| EPS | -0.31 | -0.32 | -0.28 | -0.85 |
| % Growth | 3.1% | -14.3% | 67.1% | – |
| EPS Diluted | -0.31 | -0.32 | -0.28 | -0.85 |
| Weighted Avg Shares Out | 249,685 | 236,492 | 226,960 | 70,809 |
| Weighted Avg Shares Out Dil | 249,685 | 236,492 | 226,960 | 70,809 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,553 | $1,141 | $590 | $35 |
| Interest Expense | $0 | $410 | $370 | $19 |
| Depreciation & Amortization | $3,729 | $11,076 | $14,111 | $13,699 |
| EBITDA | -$74,401 | -$64,287 | -$47,756 | -$47,110 |
| % Margin | -867.4% | -907.1% | -580.1% | -1,483.8% |